December 11, 2017 — Sectra recently announced the global introduction of gadolinium tracking in its dose monitoring solution, Sectra DoseTrack. Gadolinium is a contrast agent commonly used to enhance images during magnetic resonance imaging (MRI) exams. By systematically registering gadolinium information, healthcare providers can reduce the risk of patients experiencing negative side effects of excessively high accumulated levels of gadolinium.

Siemens Healthineers unveiled the new Mammomat Revelation premium mammography platform at the 2017 Radiological Society of North America (RSNA) Annual Meeting, Nov. 26-Dec. 1 in Chicago. Mammomat Revelation enables healthcare providers to expand precision medicine, improve clinical outcomes and increase patient satisfaction, according to the company. The system’s HD Breast Biopsy solution enables one-click targeting of suspicious areas with a +/- 1mm accuracy. The new integrated specimen imaging tool facilitates immediate control of the biopsy directly at the mammography system. Clinical workflow is improved by eliminating the need for a second imaging system and by reducing patient compression time. Mammomat Revelation also provides automated breast density measurements at the point of care. Additionally, it expands existing diagnostic options and provides patient access to functional breast imaging with contrast-enhanced mammography.